Matthew Woodworth
Adult Medicine · Burleson, TXNPI 1255993879
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations.
Across 139 payments — averaging $18.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$465
- Novo Nordisk$381
- AstraZeneca$207
- Exact Sciences$131
- Lilly USA, LLC$129
- Abbott$126
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,550100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 27 | $465 |
| Novo Nordisk | 21 | $381 |
| AstraZeneca | 13 | $207 |
| Exact Sciences | 7 | $131 |
| Lilly USA, LLC | 8 | $129 |
| Abbott | 5 | $126 |
| Johnson & Johnson(2 entities) | 5 | $119 |
| Bayer | 6 | $116 |
| Pfizer | 6 | $113 |
| Boehringer Ingelheim | 4 | $104 |
| Biogen | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Eisai Inc. | 2 | $48 |
| Dexcom, Inc. | 3 | $47 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| Philips North America LLC | 3 | $46 |
| Novartis | 3 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $43 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35 |
| Fidia Pharma USA Inc. | 2 | $34 |
| Averitas Pharma Inc. | 1 | $32 |
| IBSA Pharma Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $21 |
| Forte Bio-pharma LLC | 1 | $20 |
| GSK | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Amgen | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
| Viatris Specialty LLC | 1 | $14 |
How this compares
$2,550 in reported general payments places this provider in the 80th percentile of 98 adult medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 36 | $39,984 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $29,419 |
| OzempicSemaglutide | 20 | $26,427 |
| JardianceEmpagliflozin | 11 | $15,420 |
| MounjaroTirzepatide | 14 | $15,080 |
| Tresiba Flextouch U-200Insulin Degludec | 19 | $12,576 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $2,966 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 39 | $1,073 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 60 | $1,053 |
| Gabapentin | 60 | $1,005 |
| Sucralfate | 12 | $934 |
| Atorvastatin Calcium | 97 | $829 |
| Pregabalin | 54 | $824 |
| Cefdinir | 50 | $810 |
| Levothyroxine Sodium | 93 | $708 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $113 | $39,98436 claims |
| GSKTrelegy Ellipta | $17 | $29,41930 claims |
| Novo NordiskOzempic | $381 | $26,42720 claims |
| Boehringer IngelheimJardiance | $104 | $15,42011 claims |
| Lilly USA, LLCMounjaro | $129 | $15,08014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 98 adult medicine providers in Texas.
Other adult medicine in Burleson
- Deborah HornBellaire$723K
- Thomas MartensPflugerville$87K
- Sakuntalai SrinanthakumarBeaumont$48K
- Francisco Vera AdamesSpring$11K
- Latisha RoweHouston$11K
- Hong XiaoCarrollton$10K
- Mark NovasSheppard Afb$9K
- Daisy ArceWeslaco$9K
- Jeffory ThomasTexarkana$8K
- Manuel SanchezMcAllen$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.